Skip to main content


Intraoperative Imaging,
Expanding Access with Precision

iMRI Systems and Solutions

The τauMEDIS iMRI system incorporates a floor-based moving magnet solution to integrate state-of-the-art MRI systems into intraoperative imaging suites. This enables high-quality updated imaging during surgery, without ever moving the patient from the surgical table. The system employs a custom intraoperative MR compatible neurosurgical table and neurosurgical RF coil, and features modular construction and implementation. This design minimizes hospital renovation requirements and provides the shortest installation time on the market for a moving magnet iMRI system.

RF Coils, Surgical Tables, and Imaging Accessories

τauMEDIS RF coils provide competitive performance that match or surpass top manufacturers, delivering world-leading imaging quality. Our RF coils are available for use in intraoperative, diagnostic, and research settings, and can be developed to work in all MR field strengths (mT to T). We are currently developing a line of cable-free RF coils that provide optimized image quality coupled with workflow enhancement. Our custom solutions can be tailored to the exact needs of a client, and we pride ourselves on delivering RF coils that surpass expectations.

Standalone Brain PET Systems

The τauMEDIS standalone brain PET system delivers an exceptional cost-to-performance ratio. Our BGO crystal arrays and unique processing method allow us to offer a high-performance and highly cost-effective PET system which can be used in hospitals, clinics, or research facilities. Image reconstruction adopts a deep learning algorithm trained with PET/CT images, resulting in a PET system that does not require attenuation correction based on CT imaging, thereby reducing the amount of ionizing radiation that patients are typically exposed to.

*This product is not yet HC approved or FDA cleared

About τauMEDIS

Originally formed in 2018, and officially founded in 2023 by a group of Canadian scientists and engineers who are passionate about medical imaging, the name τauMEDIS is an acronym for tau Medical Imaging Solutions, where the Greek letter tau (τ) has significance in both magnetic resonance imaging as well as a variety of neurodegenerative diseases. With over 100 years of collective experience in the medical imaging field, the τauMEDIS team strives to provide the highest quality medical imaging solutions to hospitals, clinics, and research facilities, globally.

Winnipeg is the capital city of the Canadian province Manitoba, located roughly one hour north of the Canada/U.S.A. border, and approximately at the geographic center of North America. Winnipeg has a heritage of medical imaging R&D that stems back to the National Research Council Institute for Biodiagnostics (NRC-IBD), a research laboratory established in 1992 that aimed to investigate and develop non-invasive medical diagnostic technology for the prevention, early diagnosis, and improved treatment and prognosis of diseases. The NRC-IBD focused on the areas of magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and infrared spectroscopy (IRS), and spawned a variety of technological innovations that stood at the forefront of their respective modalities.

COO and Co-Founder

Gordon Klimenko

Gordon has over 25 years of experience with iMRI, and co-designed/installed the first FDA-cleared clinical iMRI at Boston Children's Hospital in 2004. Formerly working in the defense sector with Sperry-Univac, culminating (through acquisition) with Lockheed Martin (12 yrs), Gordon switched to the medical sector when he joined IMRIS (16 yrs). Gordon brings his knowledge of iMRI to τauMEDIS based on his five-years consulting for their sister company SCHERI. Gordon has lived his entire life in Winnipeg, is a Mopar car enthusiast, and enjoys doing his own home renovations.
Director and Co-Founder

John Saunders, Ph.D.

Dr. John Saunders has over 50 years of experience in the science and technology realm, with a particular focus on MRI imaging technology. John was the founder and initial CEO of IMRIS, later serving as the CSO of the company. John was one of the inventors of the original intraoperative MRI scanner, amongst other medical device technology. He has over 200 peer-reviewed publications, as well as seven granted US patents and 20 US patents pending.
President and Co-Founder

Michael Lang, Ph.D.

Michael received his Ph.D. in Physics from the University of Manitoba (Winnipeg, Canada) with work on hyperpolarized 129Xe gas production for high-precision co-magnetometry. He has performed R&D at both the National Research Council Institute for Biodiagnostics and IMRIS Inc. Michael’s experience includes static and dynamic magnetic field simulations, RF coil development for MR systems (1mT – 7T), active magnetic shielding development, automation and control for gas handling and cryogenic systems, project management, and regulatory affairs. He strives to make τauMEDIS a global leader in medical imaging solutions and give back to the local community.
CTO and Co-Founder

Haoqin Zhu

Haoqin has extensive experience in MRI RF engineering and has been developing RF coils for over 35 years. His work includes phased array coils, MR system body coils, multi-channel receive-only coils, TX/RX coils, and wireless inductive coils. His RF coils designs meet the top industry and research standards, often exceeding the performance of commercially available coils from world-leading commercial manufacturers. His broad experience working with commercial and research-grade MR imaging systems has led to an unparalleled ability in troubleshooting RF coils, MRI systems, and nearly every other aspect of MR hardware. His professional experience includes research and teaching at four independent universities, a senior MRI engineer position at Millennium Technology Inc. (Richmond, BC, Canada), MRI staff scientist and principal RF engineer at IMRIS Inc. (Winnipeg, MB, Canada), chief electrical engineer at Quality Electrodynamics LLC (Mayfield Village, OH, USA), and Chief Scientist at SCHERI (Hefei, China). Additionally, Haoqin holds over 23 patents and has over 31 peer-reviewed publications.

In The News

2024 SNMMI Annual Meeting

tauMEDIS will be participating in this year’s SNMMI in Toronto, Ontario, from June 8 – 11, 2024.

Come pay us a visit at booth #1810 to discuss our brain dedicated molecular imaging solutions.